WithdrawnInterventionalNot ApplicableLast updated Dec 7, 2023

Clinical Utility Study for Exo-PDAC

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Biological Dynamic's Exo-PDAC Test: A CPV® Randomized Controlled Trial

Overview

ClinicalTrials.gov ID: NCT05702385
Lead Sponsor: Qure Healthcare, LLCINDUSTRY
Brief Summary: This is a national-level research study of oncologists, interventional gastroenterologists, and primary care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
Study Type

Status

Overall Status: Withdrawn
Start Date: Sep 1, 2023Actual
Primary Completion Date: Oct 31, 2023Estimated
Completion Date: Oct 31, 2023Estimated

Study Record Dates

First Submitted: Jan 18, 2023
First Submitted that Met QC Criteria: Jan 26, 2023
First Posted: Jan 27, 2023Actual
Last Update Submitted that Met QC Criteria: Nov 30, 2023
Last Update Posted: Dec 7, 2023Actual
Last Verified: Nov 2023

NCT05200325Completed

Clinical Utility Evidence for TissueCypher®

NCT05192590Completed

Establishing Clinical Utility Evidence for Chronic Disease Management Testing

NCT05525806Completed

Clinical Utility Study for MyProstateScore+

NCT05625529Recruiting

ExoLuminate Study for Early Detection of Pancreatic Cancer

NCT05910684Completed

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

NCT03032913Completed

Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC